These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 17615799)
1. Clinical evidence for anti-inflammatory effects of antiplatelet therapy in patients with atherothrombotic disease. Steinhubl SR; Badimon JJ; Bhatt DL; Herbert JM; Lüscher TF Vasc Med; 2007 May; 12(2):113-22. PubMed ID: 17615799 [TBL] [Abstract][Full Text] [Related]
2. Randomized comparison of the effects of ASA plus clopidogrel versus ASA alone on early platelet activation in acute coronary syndromes with elevated high-sensitivity C-reactive protein and soluble CD40 ligand levels. Vavuranakis M; Latsios G; Aggelis D; Bosinakou I; Karambelas I; Tousoulis D; Toutouzas K; Stefanadis C Clin Ther; 2006 Jun; 28(6):860-71. PubMed ID: 16860169 [TBL] [Abstract][Full Text] [Related]
8. Use of antiplatelet drugs in secondary prevention in older persons with atherothrombotic disease. Aronow WS J Gerontol A Biol Sci Med Sci; 2007 May; 62(5):518-24. PubMed ID: 17522356 [TBL] [Abstract][Full Text] [Related]
9. Relationship between Inflammation and Aspirin and Clopidogrel Antiplatelet Responses in Acute Ischemic Stroke. Sternberg Z; Chichelli T; Sternberg D; Sawyer R; Ching M; Janicke D; Ambrus JL; Yu J; Munschauer F J Stroke Cerebrovasc Dis; 2016 Feb; 25(2):327-34. PubMed ID: 26586373 [TBL] [Abstract][Full Text] [Related]
11. The in-vitro effects of E5555, a protease-activated receptor (PAR)-1 antagonist, on platelet biomarkers in healthy volunteers and patients with coronary artery disease. Serebruany VL; Kogushi M; Dastros-Pitei D; Flather M; Bhatt DL Thromb Haemost; 2009 Jul; 102(1):111-9. PubMed ID: 19572075 [TBL] [Abstract][Full Text] [Related]
12. Vorapaxar: A Protease-Activated Receptor Antagonist for the Prevention of Thrombotic Events. Lam S; Tran T Cardiol Rev; 2015; 23(5):261-7. PubMed ID: 25923910 [TBL] [Abstract][Full Text] [Related]
13. Soluble P-selectin level correlates with acetylsalicylic acid but not with clopidogrel response in patients with stable coronary artery disease after a percutaneous coronary intervention. Kaufmann J; Wellnhofer E; Kappert K; Urban D; Meyborg H; Hauptmann T; Müller A; Meixner M; Graf K; Fleck E; Stawowy P Coron Artery Dis; 2013 Jun; 24(4):312-20. PubMed ID: 23549485 [TBL] [Abstract][Full Text] [Related]
14. Recent clinical trial results with antiplatelet therapy: implications in stroke prevention. Teal PA Cerebrovasc Dis; 2004; 17 Suppl 3():6-10. PubMed ID: 14730252 [TBL] [Abstract][Full Text] [Related]
15. Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease. Tran H; Anand SS JAMA; 2004 Oct; 292(15):1867-74. PubMed ID: 15494585 [TBL] [Abstract][Full Text] [Related]
16. Effect of clopidogrel with and without eptifibatide on tumor necrosis factor-alpha and C-reactive protein release after elective stenting: results from the CLEAR PLATELETS 1b study. Gurbel PA; Bliden KP; Tantry US J Am Coll Cardiol; 2006 Dec; 48(11):2186-91. PubMed ID: 17161243 [TBL] [Abstract][Full Text] [Related]
17. Antiplatelet intervention in acute coronary syndrome. Arora RR; Rai F Am J Ther; 2009; 16(5):e29-40. PubMed ID: 19092648 [TBL] [Abstract][Full Text] [Related]
18. Effects of clopidogrel and aspirin combination versus aspirin alone on platelet aggregation and major receptor expression in patients with heart failure: the Plavix Use for Treatment Of Congestive Heart Failure (PLUTO-CHF) trial. Serebruany VL; Malinin AI; Jerome SD; Lowry DR; Morgan AW; Sane DC; Tanguay JF; Steinhubl SR; O'connor CM Am Heart J; 2003 Oct; 146(4):713-20. PubMed ID: 14564328 [TBL] [Abstract][Full Text] [Related]
19. Effect of clopidogrel on the expression of inflammatory markers in rabbit ischemic coronary artery. Molero L; López-Farré A; Mateos-Cáceres PJ; Fernández-Sánchez R; Luisa Maestro M; Silva J; Rodríguez E; Macaya C Br J Pharmacol; 2005 Oct; 146(3):419-24. PubMed ID: 16041401 [TBL] [Abstract][Full Text] [Related]
20. Ongoing and planned trials of antiplatelet therapy in the acute and long-term management of patients with ischaemic brain syndromes: setting a new standard of care. Hankey GJ Cerebrovasc Dis; 2004; 17 Suppl 3():11-6. PubMed ID: 14730253 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]